SME stock: Novateor Research Lab jumps from Rs 4.44 to Rs 8.92 per share in one year; trades at 52-week high!

Novateor is a pharma company that focusses on preservative-free products for dry eyes.

Novateor is one of the buzzing stocks on BSE SME platform, with the stock gaining 11.50 per cent on Tuesday. The stock is up by 70 per cent on a YTD basis. In one year, the stock is up by more than 100 per cent.  

Novateor is a pharma company that focusses on preservative-free products for dry eyes. The products are designed to relieve evaporative dry eyes. Novateor is a part of AFT Pharmaceuticals and caters to healthcare markets in Australia & New Zealand. 

The company has been gaining momentum in the recent trading sessions. The stock is rising with higher volumes and has touched a fresh 52-week high on Tuesday at Rs 8.92 per share. Besides, the 52-week low of the stock is Rs 3.23 per share. 

Novateor is a constituent of BSE SME IPO index, which is up by more than 155 per cent in one year. S&P BSE SME IPO index is designed to measure the performance of the small & medium enterprises (SME) listed on BSE SME platform after the completion of their initial public offering (IPO).